Value of serological parameters of thyroid function in combination with ultrasound examination for differentiating Graves disease from Hashimoto thyroiditis in children

doi:10.16150/j.1671-2870.2020.06.010

Abstract

Abstract:

Objective: To analyze the serological parameters of thyroid function and features of ultrasound examination in pediatric patients with Graves' disease (GD) and Hashimoto thyroiditis (HT) so as to provide evidence for the differential diagnosis of the two diseases. Methods: A total of 226 children (aged from 7-14 years) from January 2016 to December 2019 at Children's Hospital of Nanjing Medical University were enrolled, including 124 GD children (GD group) and 102 HD (HD group). HD children were further divided into HT with hyperthyroidism (HT with hyperthyroidism group, 38 cases) and HT with hypothyroidism (HT with hypothyroidism group, 64 cases). Two hundred healthy children with matching age were served as controls. Free triiodothyronine（FT₃）, free thyroxine（FT₄）, thyroid stimulating hormone (TSH）, anti-thyroid peroxidase autoantibody（anti-TPOAb）, anti-thyroglobulin antibody（anti-TGAb） and thyroid stimulating hormone receptor antibody（TRAb） were detected with electrochemiluminescence immunoassay（ECLIA）. Indices of ultrasonography including transverse diameter and anteroposterior diameter of right and left lobes of thyroid, isthmic anteroposterior diameter were measured, and blood flow in thyroid was detected by color Doppler flow imaging (CDFI). Both the thyroid function serological parameters and features of ultrasound examination were compared between the four groups. Results: Compared with HT with hyperthyroidism group, GD group had an increased TRAb level [(18.98±20.11） IU/mL vs. (0.33±0.41) IU/L] but lower levels of anti-TPOAb [(176.10±188.84) IU/mL vs. (219.65±203.66) IU/mL] and anti-TGAb[(242.40±632.15) IU/mL vs. (471.56±361.12) IU/mL]. A further analysis showed that the positive rate of TRAb in GD group was higher than that in HT with hyperthyroidism group, while HT with hyperthyroidism group had higher positive rates of anti-TPOAb（93% vs 52%） and anti-TGAb（84% vs 49%）. Percentage of GD group with rich blood flow detected by CDFI（94%） was higher than that of HT patients with hyperthyroidism group(35%）(P<0.05). Conclusions: GD pediatric patients have similar clinical features and size of thyroid with those of HT with hyperthyroidism, which make it difficult to differentiate. Patients with higher TRAb level and abundant blood flow by CDFI imply a high possibility of GD, while those with increased levels of anti-TPOAb, anti-TGAb and non-abundant blood flow by CDFI are likely to have HT with hyperthyroidism. CDFI may provide reference for distinguishing GD from HT with hyperthyroidism

Key words: Graves' disease, Hashimoto's thyroiditis, Child

CLC Number:

R541.7

LI Songtao, YANG Daheng, SUN Hang, YUE Yulin, ZHANG Qian, LIU Qianqi, WU Su, MA Changyan. Value of serological parameters of thyroid function in combination with ultrasound examination for differentiating Graves disease from Hashimoto thyroiditis in children[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(06): 600-604.

Figures/Tables 3

References 16

[1]	胡天一, 刘戈力, 杨箐岩, 等. 儿童自身免疫性甲状腺疾病120例临床诊治和相关因素分析[J]. 天津医科大学学报, 2009, 15(1):88-91.
[2]	王波, 孟佳慧. 甲状腺自身抗体对Graves病及桥本甲状腺炎诊断的研究[J]. 中国实验诊断学, 2018, 22(2):207-209.
[3]	中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 甲状腺功能减退症基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2019, 18(11):1022-1028.
[4]	马永红. 甲状腺自身抗体在AITD患者血清中的表达及临床研究[D]. 青海: 青海大学, 2015.
[5]	中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 甲状腺功能亢进症基层诊疗指南(实践版·2019)[J]. 中华全科医师杂志, 2019, 18(12):1129-1135.
[6]	陈佩宣, 曹思敏, 吴细妹, 等. 东莞市东南片区3-6岁儿童甲状腺功能指标参考范围的建立[J]. 检验医学与临床, 2019, 16(6):828-830,856.
[7]	张久丹, 王燕燕, 陈晔, 等. 儿童自身免疫性甲状腺疾病的诊治[J/CD]. 中华临床医师杂志:电子版, 2013, 7(24):11639-11642.
[8]	Lindgren O, Asp P, Sundlov A, et al. The effect of radioiodine treatment on TRAb, anti-TPO, and anti-TG in Graves'disease[J]. Eur Thyroid J, 2019, 8(2):64-69. doi: 10.1159/000495504 pmid: 31192144
[9]	Chai H, Zhu ZJ, Chen ZQ, et al. Diagnostic value of Tg and TgAb for metastasis following ablation in patients with differentiated thyroid carcinoma coexistent with Hashimoto thyroiditis[J]. Endocr Res, 2016, 41(3):218-222. doi: 10.3109/07435800.2015.1010210 URL
[10]	汤进, 黄晓霞, 孔花娟, 等. TSH、TPOAb、TRAb、TGAb检测在甲状腺疾病临床诊断中的应用研究[J]. 现代医学, 2019, 47(7):847-850.
[11]	孙荷, 胡珊, 骆盛. Anti-TgAb和Anti-TPOAb在自身免疫性甲状腺疾病诊断中的意义[J]. 中国卫生检验杂志, 2010, 20(11):2866-2867.
[12]	李会广, 姚超峰. 血清TpoAb、TGAb在甲状腺疾病患者中的表达意义[J]. 临床医学研究与实践, 2018, 3(27): 106-108.
[13]	李玲, 马杰, 杨楷. 血清TRAB、TGAB、TPO—AB联合检测在自身免疫性甲状腺病中的临床应用[J]. 检验医学, 2016, 31(B09):108.
[14]	马玉琴. 桥本甲状腺毒症与Graves病鉴别诊断的研究[D]. 山东: 山东省医学科学院, 2007.
[15]	Andrioli M, Valcavi R. Ultrasound B-flow imaging in the evaluation of thermal ablation of thyroid nodules[J]. Endocrine, 2015, 48(3):1013-1015. doi: 10.1007/s12020-014-0302-2 URL
[16]	方建强, 程莉莉, 李维芝. 颈部淋巴结超声对Graves's病与桥本甲状腺炎的鉴别价值[J]. 肿瘤影像学, 2015, 24(4):267-270.

组别	例数(n)	FT₄(pmol/L)	FT₃(pmol/L)	TSH(μIU/mL)	anti-TPOAb(IU/mL)	anti-TGAb(IU/mL)	TRAb(IU/L)
GD组	124	54.37±33.28^a)	20.63±16.33^a)	0.04±0.18^a)	176.10±188.84^a),b)	242.40±632.15^a),b)	18.98±20.11^a),b)
HT甲亢组	38	47.93±19.84^a)	14.45±11.84^a)	0.05±0.12^a)	219.65±203.66^a)	471.56±361.12^a)	0.33±0.41^a)
HT甲减组	64	4.22±2.28^a)	3.33±2.15^a)	58.88±60.23^a)	398.56±284.56^a)	593.41±671.66^a)	4.45±9.91^a)
对照组	220	18.79±3.41	6.53±0.87	2.96±2.01	11.20±42.88	10.00±16.35	0.30±0.77

组别	例数(n)	anti-TPOAb	anti-TGAb	TRAb
GD组	124	64(52)^a),b)	61(49)^a),b)	116(93)^a),b)
HT甲亢组	38	36(93)^a)	32（84)^a)	13(33)^a)
对照组	220	22(10)	15(7)	8(4)

组别	例数（n）	右叶横径(cm)	右叶前后径(cm)	左叶横径(cm)	右叶前后径(cm)	峡部前后径(cm)	血流丰富检出率[n(%)]
GD组	124	2.07±0.59^a)	1.91±0.55^a)	1.97±0.71^a)	1.84±0.62^a)	5.71±4.09^a)	117(94)^a),b）
HT甲亢组	38	1.93±0.48^a）	1.79±0.47^a）	2.01±0.51^a）	1.97±0.81^a）	4.34±2.01^a）	13(35)^a）
HT甲减组	64	1.89±0.91^a）	1.43±0.52^a）	2.21±0.61^a）	2.11±0.77^a）	4.89±2.18^a）	26(41)^a）
对照组	220	0.81±0.19	0.49±0.14	0.79±0.19	0.52±0.11	0.12±0.04	0(0%)